Flagellate purpura associated with COVID-19 vaccination
J Eur Acad Dermatol Venereol
.
2022 Jan;36(1):e33-e34.
doi: 10.1111/jdv.17609.
Epub 2021 Sep 9.
Authors
E Heck
1
,
B D Rankin
2
,
M Schneider
3
,
V H Prajapati
1
4
5
6
7
8
Affiliations
1
Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
2
Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
3
Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada.
4
Dermatology Research Institute, Calgary, Alberta, Canada.
5
Skin Health & Wellness Centre, Calgary, Alberta, Canada.
6
Probity Medical Research, Calgary, Alberta, Canada.
7
Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.
8
Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.
PMID:
34416052
PMCID:
PMC8656622
DOI:
10.1111/jdv.17609
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
Purpura* / etiology
SARS-CoV-2
Vaccination / adverse effects
Substances
COVID-19 Vaccines